» Articles » PMID: 11689882

A Subset of Lupus Anti-DNA Antibodies Cross-reacts with the NR2 Glutamate Receptor in Systemic Lupus Erythematosus

Overview
Journal Nat Med
Date 2001 Nov 2
PMID 11689882
Citations 265
Authors
Affiliations
Soon will be listed here.
Abstract

In systemic lupus erythematosus, antibodies against double-stranded DNA are a major contributor to renal disease. We have previously demonstrated that the pentapeptide Asp/Glu-Trp-Asp/Glu-Tyr-Ser/Gly is a molecular mimic of double-stranded DNA. This sequence is also present in the extracellular domain of murine and human NMDA (N-methyl-D-aspartate) receptor subunits NR2a and NR2b. Here we show that the NR2 receptor is recognized by both murine and human anti-DNA antibodies. Moreover, anti-DNA antibodies with this cross-reactivity mediate apoptotic death of neurons in vivo and in vitro. Finally, we show that the cerebrospinal fluid of a patient with systemic lupus erythematosus contains these antibodies and also mediates neuronal death via an apoptotic pathway. These observations indicate that lupus antibodies cross-react with DNA and NMDA receptors, gain access to cerebrospinal fluid and may mediate non-thrombotic and non-vasculitic abnormalities of the central nervous system.

Citing Articles

ActiLup: is it feasible? High-intensity interval training in systemic lupus erythematosus patients with fatigue: protocol for a prospective, monocentric proof-of-concept study.

Dreher M, Petros S, Engelhardt S, Geselle L, Baab J, Wicke T BMJ Open Sport Exerc Med. 2025; 11(1):e002403.

PMID: 39974335 PMC: 11836837. DOI: 10.1136/bmjsem-2024-002403.


Why is it so difficult to understand why we don't understand human systemic lupus erythematosus? Contemplating facts, conflicts, and impact of "the causality cascade paradigm".

Rekvig O Front Immunol. 2025; 15:1507792.

PMID: 39936150 PMC: 11811100. DOI: 10.3389/fimmu.2024.1507792.


Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders.

Blaylock R Surg Neurol Int. 2025; 16:26.

PMID: 39926461 PMC: 11799683. DOI: 10.25259/SNI_1114_2024.


Opportunities and limitations of B cell depletion approaches in SLE.

Stockfelt M, Teng Y, Vital E Nat Rev Rheumatol. 2025; 21(2):111-126.

PMID: 39815102 DOI: 10.1038/s41584-024-01210-9.


Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.

Goldbach-Mansky R, Alehashemi S, de Jesus A Nat Rev Rheumatol. 2024; 21(1):22-45.

PMID: 39623155 DOI: 10.1038/s41584-024-01184-8.